Ticker Details
Olema Pharmaceuticals, Inc.
IPO Date:	November 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.07B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.57 | 4.42%
Avg Daily Range (30 D):	$0.44 | 3.91%
Avg Daily Range (90 D):	$0.48 | 3.28%

Institutional Daily Volume
Avg Daily Volume:	.67M
Avg Daily Volume (30 D):	1.49M
Avg Daily Volume (90 D):	1.3M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	1,278
Avg Institutional Trade:	$1.99M
Avg Institutional Trade (30 D):	$2.12M
Avg Institutional Trade (90 D):	$2.39M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.67M
Avg Closing Trade (30 D):	$3.33M
Avg Closing Trade (90 D):	$3.57M
Avg Closing Volume:	182.86K

News

May 26, 2026 @ 11:00 AM Olema Oncology Announces Clinical Trial Collaborat... Source: Na

May 21, 2026 @ 9:00 PM Olema Oncology Announces Encouraging Initial Clini... Source: Olema Oncology

May 20, 2026 @ 5:00 PM ESR1-Mutated Metastatic Breast Cancer Market Expec... Source: Delveinsight

Mar 16, 2026 @ 11:00 AM Olema Oncology Reports Fourth Quarter and Full Yea... Source: Na

Mar 9, 2026 @ 5:57 PM Olema Pharmaceuticals, Inc. Investigated on Behalf... Source: Business Wire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.03	$-.52	$-.51
Diluted EPS	$-2.03	$-.52	$-.51
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-185.15M	$-53.09M	$-46.06M
Operating Income / Loss	$-201.81M	$-57.99M	$-50.08M
Cost of Revenue
Net Cash Flow	$1.91M	$4.25M	$13.04M
PE Ratio